Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker EPR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Elizabeth Grace SVP - Human Resources & Admin | EPR EPR Properties | Sale | 4,200 | $60.57 | $254.4K Sale | Form 4 ↗ |
| Aug 6, 2026 | Robin Peppe Sterneck Director | EPR EPR Properties | Sale | 3,403 | $61.54 | $209.4K Sale | Form 4 ↗ |
| Aug 3, 2026 | Tonya L. Mater SVP & Chief Accounting Officer | EPR EPR Properties | Sale | 3,092 | $61.76 | $191.0K Sale | Form 4 ↗ |
| Aug 3, 2026 | Tonya L. Mater SVP & Chief Accounting Officer | EPR EPR Properties | Sale | 3,600 | $61.82 | $222.6K Sale | Form 4 ↗ |
| Jul 17, 2026 | Gwendolyn Mary Johnson SVP - Asset Management | EPR EPR Properties | Sale | 1,000 | $62.50 | $62.5K Sale | Form 4 ↗ |
| Jul 7, 2026 | Gwendolyn Mary Johnson SVP - Asset Management | EPR EPR Properties | Sale | 1,000 | $60.00 | $60.0K Sale | Form 4 ↗ |
| Jun 23, 2026 | Paul Robert Turvey SVP, General Counsel | EPR EPR Properties | Sale | 6,400 | $58.20 | $372.5K Sale | Form 4 ↗ |
| Jun 23, 2026 | Gwendolyn Mary Johnson SVP - Asset Management | EPR EPR Properties | Sale | 2,000 | $58.11 | $116.2K Sale | Form 4 ↗ |
| Jun 10, 2026 | Mark Alan Peterson EVP & Chief Financial Officer | EPR EPR Properties | Sale | 8,334 | $60.00 | $500.0K Sale | Form 4 ↗ |
| May 7, 2026 | Mark Alan Peterson EVP & Chief Financial Officer | EPR EPR Properties | Sale | 8,696 | $57.50 | $500.0K Sale | Form 4 ↗ |
| Apr 15, 2026 | Tonya L. Mater SVP & Chief Accounting Officer | EPR EPR Properties | Sale | 2,600 | $56.50 | $146.9K Sale | Form 4 ↗ |
| Apr 14, 2026 | Tonya L. Mater SVP & Chief Accounting Officer | EPR EPR Properties | Sale | 2,000 | $56.00 | $112.0K Sale | Form 4 ↗ |
| Apr 14, 2026 | Mark Alan Peterson EVP & Chief Financial Officer | EPR EPR Properties | Sale | 9,091 | $55.00 | $500.0K Sale | Form 4 ↗ |
| Mar 16, 2026 | Brian Andrew Moriarty SVP - Corporate Communications | EPR EPR Properties | Sale | 5,000 | $56.44 | $282.2K Sale | Form 4 ↗ |
| Mar 10, 2026 | Lisa G. Trimberger Director | EPR EPR Properties | Sale | 3,000 | $57.38 | $172.1K Sale | Form 4 ↗ |
| Mar 10, 2026 | Lisa G. Trimberger Director | EPR EPR Properties | Sale | 6,633 | $57.83 | $383.6K Sale | Form 4 ↗ |
| Feb 2, 2026 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $53.89 | $404.2K Sale | Form 4 ↗ |
| Jan 2, 2026 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $50.07 | $375.5K Sale | Form 4 ↗ |
| Dec 1, 2025 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $52.25 | $391.9K Sale | Form 4 ↗ |
| Nov 3, 2025 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $49.21 | $369.1K Sale | Form 4 ↗ |
| Oct 1, 2025 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $58.12 | $435.9K Sale | Form 4 ↗ |
| Sep 2, 2025 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $53.35 | $400.1K Sale | Form 4 ↗ |
| Aug 1, 2025 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $54.94 | $412.1K Sale | Form 4 ↗ |
| Jul 1, 2025 | Gregory E. Zimmerman EVP & Chief Investment Officer | EPR EPR Properties | Sale | 7,500 | $58.37 | $437.8K Sale | Form 4 ↗ |
| Jun 13, 2025 | Robin Peppe Sterneck Director | EPR EPR Properties | Sale | 3,796 | $56.73 | $215.3K Sale | Form 4 ↗ |
| May 20, 2025 | Robin Peppe Sterneck Director | EPR EPR Properties | Sale | 3,806 | $53.97 | $205.4K Sale | Form 4 ↗ |
| Mar 18, 2025 | Mark Alan Peterson EVP & Chief Financial Officer | EPR EPR Properties | Sale | 13,700 | $51.77 | $709.2K Sale | Form 4 ↗ |
| Mar 17, 2025 | Brian Andrew Moriarty SVP - Corporate Communications | EPR EPR Properties | Sale | 2,500 | $51.99 | $130.0K Sale | Form 4 ↗ |
| Mar 17, 2025 | Tonya L. Mater SVP & Chief Accounting Officer | EPR EPR Properties | Sale | 3,120 | $51.90 | $161.9K Sale | Form 4 ↗ |
| Mar 3, 2025 | Gwendolyn Mary Johnson SVP - Asset Management | EPR EPR Properties | Sale | 3,900 | $54.02 | $210.7K Sale | Form 4 ↗ |
30 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:14 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances